Nuwellis Gets U.S. Patent for Blood Filtering Machine and Methods

Dow Jones
07/16
 

By Kelly Cloonan

 

Nuwellis has received a U.S. patent for its blood filtering system design and methods.

The medical technology company said Tuesday the patent covers methods for improving the accuracy of fluid balance calculations by incorporating the density of replacement fluids and effluent.

Most continuous renal replacement therapy systems assume a default fluid density, but actual fluid densities vary. If left uncorrected, that discrepancy can lead to clinically relevant fluid balance errors, the company said.

Nuwellis's design enables systems to account for density via user input, machine measurement, or derived data for more accurate volumetric flow tracking, the company said.

 

Write to Kelly Cloonan at kelly.cloonan@wsj.com

 

(END) Dow Jones Newswires

July 15, 2025 16:28 ET (20:28 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10